Investors – Calliditas Therapeutics AB

Press releases

May 14, 2021Calliditas Therapeutics to host conference call to provide Business Update for the first quarter of 2021
May 3, 2021Calliditas promotes Andrew Udell to President, North America
Apr 28, 2021FDA grants priority review for Nefecon, for patients with IgA nephropathy

On May 18^th, 2021, Calliditas Therapeutics AB (publ) (”Calliditas”) will publish its financial report for the first quarter of 2021, and at 2.30 pm CET will host a conference call to present and discuss the results.

Press release
Webcast

Read the invitation

Calendar

May 18, 2021Interim report for the period January 1 – March 31, 2021
May 27, 2021Annual General Meeting 2021
Aug 19, 2021Interim report for the period January 1 – June 30, 2021

All events

Press releases

Share price Sweden

Share price US

Interim Report Q1 2021

Calendar